Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02005614 : A Pilot/Phase II Study of Gamma Knife Radiosurgery for Brain Metastases Using 3Tesla MRI and Rational Dose Selection
PhasePhase 2
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria:

- Patients must have histologically or cytologically confirmed malignancy (not leukemia
or lymphoma). There must be metastatic brain disease apparent on magnetic resonance
imaging which offers a medical indication for brain radiation. - Age > 18

- Karnofsky Performance Status > 70

- MRI performed within 4 weeks of trial enrollment

- Medical oncologist or consenting physician verifies that chemotherapy options exist
after treatment with intracranial therapy, and that chemotherapy is planned to
initiate after completion of radiation. Or, survival as estimated by the medical
oncologist or enrolling physician is > 3 months.

Exclusion Criteria:

- Extremely radiosensitive tumor (lymphoma, leukemia)

- Radiosensitivity syndrome (scleroderma, dermatomyositis, other genetic syndrome that
predisposes to adverse radiotherapy complications)

- Evidence of leptomeningeal dissemination

- Resection of brain metastases, otherwise untreated with radiation for those brain
lesions (presenting for postoperative consolidative radiotherapy)

- Presence of a medical device (pacemaker, stent) or allergy that precludes contrast
enhanced MRI

- Patient is unable to tolerate placement of a stereotactic headframe

- Pregnancy
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02005614      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740